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Abstract 
Objectives: This study was undertaken to determine whether a causative relationship exists 
between the development of hypo high-density-lipoprotein (HDL) cholesterolemia and 
increased high-sensitivity C-reactive protein (HsCRP).  
Methods: The target population comprised 6985 male workers at a Japanese steel company. 
The prospective cohort study was performed over a 5-year period, and annual health 
screening information was analyzed by a pooled logistic-regression method.  
Results: A significant relationship between the development of hypo HDL cholesterolemia 
and increased HsCRP was observed, after adjusting for confounding factors such as various 
blood chemistry parameters and lifestyle factors (smoking, drinking, exercise, meals), job 
schedule type and job stress. The odds ratio of a 1.5-fold increase in HsCRP was 1.05 
(95%CI: 1.03-1.08). 
Conclusions: The results suggested that an increase of HsCRP is associated with the 
development of hypo-HDL- cholesterolemia. 
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I. Introduction 
 
A number of epidemiological and clinical studies have shown a relation between plasma 
high-density-lipoprotein (HDL) cholesterol level and atherosclerotic diseases [1-5]. This 
makes it important to identify factors that promote decreased HDL levels to help prevent 
atherosclerotic diseases. On the other hand, high-sensitive C-reactive protein (HsCRP) is a 
protein marker of acute phase and systemic inflammation. A significant relationship has also 
been demonstrated between HsCRP and atherosclerotic diseases [6-8]. Many studies are 
available on the relationship between HDL levels and HsCRP level, most of which have 
demonstrated a negative association between HsCRP and HDL [9-13]. Therefore, it is 
generally considered that high levels of HsCRP promote low levels of HDL. However, almost 
all of the previous studies showing a negative association between HsCRP and HDL were 
cross-sectional in nature.  
In terms of effect of inflammation on low HDL cholesterol level, Zuliani et al. [14] 
indicated that interleukin 6, together with other cytokines, might influence HDL cholesterol 
levels by modifying the activity of the triglycerides lipases. It has been shown that 
pro-inflammatory cytokines inhibit the activity of lipoprotein lipase [14, 15], and enhance the 
lipolytic activity of endothelial lipase [14, 16], Both these actions have been associated with 
low HDL-C levels during acute or chronic inflammatory states [14]. On the other hand, HDL 
cholesterol may decrease CRP level by its anti-inflammatory effects including inhibition of 
cytokine-induced adhesion molecule expression in endothelial cells, inhibition of monocyte 
adhesion to the endothelium, inhibition of monocyte activation resulting in an inhibition of 
proinflammatory cytokines and chemokine production, reduction of neutrophil activation and 
inhibition of neutrophil infiltration in the arterial wall [17].  
Therefore, from the epidemiological point of view, cohort studies are necessary to 
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demonstrate any causative relationship between HsCRP and HDL, but to our knowledge no 
such cohort studies have been published.  
This promoted us to examine the relationship between levels of HsCRP and HDL by means 
of a cohort study and to clarify whether a causative relationship exists between them or not. 
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II. Materials and Methods 
2.1. Study population and measurements 
 
This prospective cohort study included observations made over a 5-year period from 2005 
to 2010. A total of 6985 subjects out of a possible 9546 male workers at a Japanese steel 
company were enrolled. The following individuals were excluded from this study: those who 
did not receive a health examination in the subsequent year (869 men), those for whom the 
measurement of HDL was missing in the subsequent year (596 men), those who had a history 
of collagen disease (48 men), those who had been diagnosed with hypo-HDL-cholesterolemia 
based on the criteria in the present study (955 men), and those with any missing data in the 
year of entry (93 men). 
 
The health examinations were carried out between 09:00 and 15:00 throughout the study 
period, with none of the measurements taken within 30 minutes of a meal or heavy physical 
activity. Occupational physicians carried out the examination and verified the medical history. 
The endpoints in the study were defined as follows: A value of HDL cholesterol less than 
40mg/dl, and/or starting to take an antilipotropic drug. We used the cut-off value of HDL 
cholesterol of 40mg/dl because the Japan Atherosclerosis Society defines 
hypo-HDL-cholesterolemia as an HDL cholesterol of less than 40mg/dL [18]. The annual 
health examination contained the serum HsCRP level, which was measured by alatex 
turbidimetric immunoassay method [19]. The minimum detectable concentration and 
interassay coefficient of variation for HsCRP were 0.02 mg/dL and 2.43%, respectively. Age, 
body mass index (BMI), systolic blood pressure, diastolic blood pressure, HDL cholesterol, 
HbA1c, aspartate aminotransferase (AST), creatinine and uric acid were measured during the 
study, with alcohol consumption, soft drink consumption, and smoking and exercise habits 
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serving as covariates in the analyses. All covariates were updated whenever the annual health 
examination was carried out. We calculated the value of mean arterial pressure (MAP) using 
the equation (diastolic blood pressure ×2 + systolic blood pressure)/3 [20]. Type of job 
schedules, habitual exercise, cooking by oneself or other, soft-drink consumption, smoking 
habits and snacking between meals were recorded using self-administered questionnaires 
during the health examination. Type of job schedule was categorized as daytime, three-shift 
work, two-shift work, or other, and in the same way, smoking habits as non-smoker or 
smoker; habitual exercise as none, 1-2 times/ month, 1-2 times/ week, 3-4 times/ week  or 
≧5 times/ week; meals as cooked by oneself, cooked by family member, eating out or 
catering, eating in a dormitory or other; soft-drink consumption as rare, occasional or 
frequent; and snacking between meals as rare, occasional or frequent. The volume of alcohol 
in each type of alcoholic beverage was calculated using the unit ‘gou’. In Japan ‘gou’ is the 
most common unit used to measure alcohol consumption: 1 gou (180 mL) of Japanese sake 
(rice wine) contains approximately 22 g of ethanol, and is equivalent to 500 mL of beer, 60 
mL of whiskey, 180 mL of wine and 110 mL of shochu (distilled spirits). This unit was used 
in the questionnaire as it is easily comprehensible by the general Japanese population to 
determine the amount of alcohol beverages consumed. Weekly alcohol intake was estimated 
by multiplying quantity by frequency. Job-related stress factors were evaluated by the Brief 
Job Stress Questionnaire (BSJQ) [21] and were included as covariates. 
The study protocol was approved by the Ethics Review Board of the Graduate School of 
Medicine, Chiba University. 
 
2.2. Statistical analysis 
A pooled logistic-regression analysis was used to examine the relationship between HsCRP 
and the development of hypo-HDL-cholesterolemia. The HsCRP, HDL HbA1c, AST, 
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creatinine and uric acid were log-transformed. In a pooled regression analysis, each 
examination interval of 1 year was treated as a mini follow-up study. The parameters obtained 
at the beginning of each 1-year follow-up were linked to the development of 
hypo-HDL-cholesterolemia at the end of the follow-up. Then, these 1-year follow-ups were 
pooled and the relationships between parameters obtained in the development of 
hypo-HDL-cholesterolemia were analyzed using a logistic-regression model [22]. The 
analyses were performed using IBM SPSS 19J statistical software (IBM Business Analytics, 
Tokyo, Japan). P values < 0.05 were considered statistically significant. 
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III. Results 
 
Characteristics of the subjects for hypo-HDL-cholesterolemia at study entry year are 
presented in Table 1. The mean age was 44.6 years. The geometric mean (GM) of HsCRP 
was 0.05 mg/dL and the GM of HDL cholesterol was 54.9 mg/dL. Table 2 shows the number 
of person-years studied and incidence rate. The number of subjects who developed hypo 
HDL-cholesterolemia was 1156 and the incidence rate was 16.5%. Table 3 shows the odds 
ratios (OR) and 95% confidence intervals (CI) for the development of 
hypo-HDL-cholesterolemia. The data of HsCRP, HbA1c, aspartate aminotransferase, 
creatinine, and uric acid were logarithmically transformed using a base of 1.5. This shows that 
increased serum HsCRP was associated with hypo-HDL-cholesterolemia. The OR of a 
1.5-fold increase in HsCRP for the development of hypo-HDL-cholesterolemia was 1.05 
(95%CI: 1.03-1.08). BMI [OR(95%CI): 1.10 (1.08-1.12)], HbA1c [OR(95%CI): 1.66 
(1.34-2.06)], creatinine level [OR(95%CI): 1.24 (1.08-1.43)], smoking habit [OR(95%CI): 
1.56 (1.37-1.78)] and little habitual exercise (0 times [OR(95%CI): 1.37 (1.04-1.82)] or 
once-twice/month [OR(95%CI): 1.41 (1.05-1.90)]) had associations with the development of 
hypo-HDL-cholesterolemia, while alcohol consumption [OR(95%CI): 0.95 (0.93-0.96)] and 
job demand [OR(95%CI): 0.82 (0.73-0.93)] had negative associations.  
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IV. Discussion 
 
This study demonstrated that high HsCRP had an effect on the development of 
hypo-HDL-cholesterolemia in Japanese male workers even after adjusting for potential 
confounders. To our knowledge, few studies have demonstrated a relationship between high 
HsCRP and the development of hypo-HDL-cholesterolemia, using a cohort method. Salient 
points of this study are as follows. First, it used data from a large number of persons (6,985 
men). The data included blood chemical data, data on diverse lifestyle factors such as 
smoking, drinking, exercise, meals, and job schedule type and job stress. Numerous 
confounding factors were included and adjusted for in defining the relationship between 
HsCRP and the development of hypo-HDL-cholesterolemia. Second, pooled logistic 
regression analysis was used for analyzing the relationship between HsCRP and the 
development of hypo-HDL-cholesterolemia. The annual health examination was performed 
from 2005 to 2010 and all of the data from this 6-year period could be used and evaluated by 
this analytical method. A pooled regression analysis is appropriate and very effective for 
analysis of the data from multiple years and can adjust for covariates as well. In addition, this 
study excluded participants with chronic inflammatory disease and 
hypo-HDL-cholesterolemia at the start. 
On the basis of these findings, it can be said that high HsCRP level promotes 
hypo-HDL-cholesterolemia. The mechanism underlying this finding is unclear, however, and 
will require further study. 
In addition, this study demonstrated that BMI, HbA1c, creatinine level, smoking habit and 
little habitual exercise (0 times or once-twice/month) were similarly associated with the 
development of hypo-HDL-cholesterolemia. In the present study, the ORs for other 
significant factors were generally larger than that of HsCRP. Therefore, the impact of HsCRP 
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on the development of hypo-HDL-cholesterolemia may be limited compared to other 
significant factors such as obesity or lifestyle factors. On the other hand, after the 
standardization of significant ORs based on the geometric standard deviation of each 
biochemical measurements, the ORs were estimated to be 1.15, 1.15 and 1.09 for HsCRP, 
HbA1c and creatinine, respectively. Therefore, we consider that the relative impact of HsCRP 
were comparable to those for HbA1c and creatinine. On the other hand, alcohol consumption 
and job demand showed negative associations. It is also important to elucidate the 
significance of the above factors in the development of hypo-HDL-cholesterolemia. We are 
planning to further investigate the relationship between the above-noted factors and 
development of hypo-HDL-cholesterolemia in a longer prospective cohort study. 
In this company, the workers who had abnormal finding at the annual health examination 
received the health guidance by a physician or an occupational health nurse. However, we 
consider such health guidance did not biased the results because of the adjustment for various 
factors related to the behavioral change by the health guidance, such as the body mass index, 
blood pressure, lifestyles and blood biochemistries. 
In conclusion, using a pooled logistic regression analysis of the annual health examination 
data of about seven thousand Japanese male workers, this study demonstrated that elevated 
HsCRP is associated with the development of hypo-HDL-cholesterolemia. 
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Table 1. Characteristics of subjects for hypo-HDL-cholesterolemia at study entry year in men 
 Men 
 Mean (SD
*
) 
Age (yrs) 44.6 (12.1) 
Body mass index (kg/m
2
) 23.6 (3.2) 
Systolic blood pressure (mmHg) 129.6 (13.2) 
Diastolic blood pressure (mmHg) 78.7 (9.0) 
Mean blood pressure (mmHg) 95.7 (9.7) 
Alcohol consumption (gou/week) 5.4 (6.0) 
 GM
†
 (GSD
‡
) 
C-reactive protein (mg/dL) 0.05 (2.9) 
HDL cholesterol (mg/dL) 54.9 (1.2) 
HbA1c (%) 5.2 (1.1) 
Aspartate aminotransferase (IU/L) 21.7 (1.4) 
Creatinine (mg/dL) 0.8 (1.2) 
Uric acid (mg/dL) 5.7 (1.3) 
Job Schedule type  
Daytime 60.4% 
3-shiftwork 32.7% 
2-shiftwork 5.2% 
Others 1.7% 
Smoking  
Nonsmoker 46.7% 
Smoker 53.3% 
Habitual exercise  
None 37.3% 
once-twice/month 19.0% 
once-twice/week 27.2% 
3-4 times/week 10.5% 
5 times/week or more 6.1% 
Meals  
Cooked by oneself 6.0% 
Cooked by family 80.5% 
Eating out or catering 6.2% 
Eating in the dormitory 6.5% 
Others 0.7% 
Soft drink consumption  
Rare 27.6% 
Occasional 46.5% 
Frequent 25.8% 
In-between snacking  
Rare 41.5% 
Occasional 50.2% 
Frequent 8.3% 
Brief Job Stress Questionnaire  
Job demand (High) 44.5% 
Job control (Low) 38.8% 
Interpersonal relationship (Low) 17.5% 
Compatibility (Low) 20.0% 
*
Standard deviation. †Geometric mean. ‡Geometric standard deviation. 
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Table 2. Number of person-years studied and incidence rate. 
 Men 
Number of subjects examined 6,985 
Number of subjects who developed 
hypo-HDL-cholesterolemia 
1,156 
(%) 16.5  
Total person-years of observation 19,502 
Incidence rate per 1,000 person years 59.3 
Mean observed years per person 2.79  
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Table 3. Odds ratios and 95% confidence intervals for the  
development of hypo-HDL-cholesterolemia in men.  
Men   
Independent variables OR
*
 (95%CI
†
) P 
C-reactive protein (mg/dL) 1.05 (1.03-1.08) <0.001 
Age (yrs) 1.01 (1.00-1.01) 0.056 
Alcohol consumption (gou/week) 0.95 (0.93-0.96) <0.001 
Body mass index (kg/m
2
) 1.10 (1.08-1.12) <0.001 
Mean blood pressure 1.00 (0.99-1.01) 0.691 
HbA1c(%) 1.66 (1.34-2.06) <0.001 
Aspartate aminotransferase (IU/L) 1.06 (0.98-1.14) 0.152 
Creatinine (mg/dL) 1.24 (1.08-1.43) 0.003 
Uric acid (mg/dL) 1.10 (0.98-1.24) 0.112 
Job schedule type(/daytime
‡
)     
3-shiftwork 1.06 (0.92-1.22) 0.403 
2-shiftwork 0.90 (0.67-1.19) 0.453 
Others 0.67 (0.38-1.16) 0.155 
Smoking habit (/nonsmoker
‡
)     
Smokers 1.56 (1.37-1.78) <0.001 
Habitual exercise (/≥5 times/week‡)     
Absence 1.37 (1.04-1.82) 0.026 
once-twice/month 1.41 (1.05-1.90) 0.023 
once-twice/week 1.24 (0.93-1.65) 0.145 
3-4 times/week 1.08 (0.78-1.49) 0.639 
Meals (/Cooked by family
‡
)   
Cooked by oneself 0.81 (0.61-1.06) 0.127 
Eating out or catering 1.15 (0.91-1.45) 0.249 
Eating in a dormitory 0.93 (0.69-1.25) 0.640 
Others 0.94 (0.43-2.04) 0.871 
Soft drink consumption (/rare
‡
)     
Occasional 1.09 (0.93-1.27) 0.307 
Frequent 1.19 (0.99-1.43) 0.068 
In-between snacking (/rare
‡
)   
Occasional 0.94 (0.82-1.09) 0.419 
Frequent 1.11 (0.88-1.41) 0.375 
Brief Job Stress Questionnaire     
Job demand (High/low
‡
) 0.82 (0.73-0.93) 0.002 
Job control (Low/high
‡
) 1.01 (0.89-1.16) 0.861 
Interpersonal relationship (Low/high
‡
) 1.03 (0.87-1.21) 0.738 
Compatibility (Low/high
‡
) 1.11 (0.95-1.29) 0.198 
*
 Odds ratios adjusted for the effect of all other covariates using pooled logistic  
regression. 
†
 95% confidence interval. 
‡
Control categories. The data of  
C-reactive protein, HbA1c, aspartate aminotransferase, creatinine, and uric acid  
were logarithmically transformed using a base of 1.5. 
 
 
17 
 
-
9546 men who underwent 
annual health examination at a 
Japanese steel company
Target participants: 6985 men
Exclusion
• Missing health examination in the 
next year: 869 men
• Missing HDL in the next year: 596 
men 
• History of collagen disease: 48 
men
• Diagnosis of hypo-HDL-
cholesterolemia: 955 men
• Any missing data in the year of 
entry: 93 men
Endpoint
• HDL cholesterol < 40mg/dL
• starting to take an antilipotropic drug
 
Fig 1. Study design and participants 
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